- Home
- AVO vs TRVI Comparison
AVO vs TRVI Comparison
Compare AVO & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVO
- TRVI
- Stock Information
- Founded
- AVO 1983
- TRVI 2011
- Country
- AVO United States
- TRVI United States
- Employees
- AVO N/A
- TRVI N/A
- Industry
- AVO Farming/Seeds/Milling
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- AVO Consumer Staples
- TRVI Health Care
- Exchange
- AVO Nasdaq
- TRVI Nasdaq
- Market Cap
- AVO 836.8M
- TRVI 725.7M
- IPO Year
- AVO 2020
- TRVI 2019
- Fundamental
- Price
- AVO $12.05
- TRVI $7.87
- Analyst Decision
- AVO Strong Buy
- TRVI Strong Buy
- Analyst Count
- AVO 2
- TRVI 9
- Target Price
- AVO $15.50
- TRVI $19.94
- AVG Volume (30 Days)
- AVO 282.6K
- TRVI 1.9M
- Earning Date
- AVO 09-08-2025
- TRVI 08-07-2025
- Dividend Yield
- AVO N/A
- TRVI N/A
- EPS Growth
- AVO 108.17
- TRVI N/A
- EPS
- AVO 0.52
- TRVI N/A
- Revenue
- AVO $1,392,900,000.00
- TRVI N/A
- Revenue This Year
- AVO $8.85
- TRVI N/A
- Revenue Next Year
- AVO N/A
- TRVI N/A
- P/E Ratio
- AVO $23.34
- TRVI N/A
- Revenue Growth
- AVO 29.50
- TRVI N/A
- 52 Week Low
- AVO $9.56
- TRVI $2.36
- 52 Week High
- AVO $15.25
- TRVI $8.11
- Technical
- Relative Strength Index (RSI)
- AVO 51.84
- TRVI 74.32
- Support Level
- AVO $12.00
- TRVI $6.67
- Resistance Level
- AVO $12.45
- TRVI $8.11
- Average True Range (ATR)
- AVO 0.29
- TRVI 0.41
- MACD
- AVO -0.03
- TRVI 0.17
- Stochastic Oscillator
- AVO 38.93
- TRVI 89.66
About AVO Mission Produce Inc.
Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.